{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:14:23Z","timestamp":1753892063343,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Carnitine palmitoyltransferase 1A (CPT1A) deficiency is an inherited disorder of mitochondrial fatty acid \u03b2-oxidation that impairs fasting ketogenesis and gluconeogenesis in the liver. Few studies implementing newborn screening (NBS) for CPT1A deficiency in the Chinese population have been reported. This study aimed to determine the biochemical, clinical, and genetic characteristics of patients with CPT1A deficiency in China. A total of 204,777 newborns were screened using tandem mass spectrometry at Quanzhou Maternity and Children's Hospital between January 2017 and December 2018. Newborns with elevated C0 levels were recruited, and suspected patients were subjected to further genetic analysis. Additionally, all Chinese patients genetically diagnosed with CPT1A deficiency were reviewed and included in the study. Among the 204,777 screened newborns, two patients were diagnosed with CPT1A deficiency; thus, the estimated incidence in the selected population was 1:102,388. In addition to the two patients newly diagnosed with CPT1A deficiency, we included in our cohort 10 Chinese patients who were previously diagnosed. Five of these 12 patients were diagnosed <jats:italic>via<\/jats:italic> NBS. All patients exhibited elevated C0 and\/or C0\/(C16+C18) ratios. No clinical symptoms were observed in the five patients diagnosed <jats:italic>via<\/jats:italic> NBS, while all seven patients presented with clinical symptoms, including fever, cough, vomiting, diarrhea, and seizures. Eighteen distinct <jats:italic>CPT1A<\/jats:italic> variants were identified, 15 of which have been previously reported. The three novel variants were c.272T&amp;gt;C (p.L91P), c.734G&amp;gt;A (p.R245Q), and c.1336G&amp;gt;A (p.G446S). <jats:italic>in silico<\/jats:italic> analysis suggested that all three novel variants were potentially pathogenic. The most common variant was c.2201T&amp;gt;C (p.F734S), with an allelic frequency of 16.67% (4\/24). Our findings demonstrated that NBS for CPT1A deficiency is beneficial. The three novel variants expand the mutational spectrum of <jats:italic>CPT1A<\/jats:italic> in the Chinese population, and c.2201T&amp;gt;C (p.F734S) may be a potential hotspot <jats:italic>CPT1A<\/jats:italic> mutation.<\/jats:p>","DOI":"10.3389\/fped.2021.771922","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T06:43:38Z","timestamp":1636699418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Three Novel and One Potential Hotspot CPT1A Variants in Chinese Patients With Carnitine Palmitoyltransferase 1A Deficiency"],"prefix":"10.3389","volume":"9","author":[{"given":"Weifeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1542\/peds.2011-2924","article-title":"Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia First Nations","volume":"130","author":"Sinclair","year":"2012","journal-title":"Pediatrics."},{"key":"B2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.braindev.2009.03.004","article-title":"Molecular analysis of a presymptomatic case of carnitine palmitoyl transferase I (CPT I) deficiency detected by tandem mass spectrometry newborn screening in Japan","volume":"32","author":"Tsuburaya","year":"2010","journal-title":"Brain Dev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jpeds.2011.08.032","article-title":"Carrier frequency of a common mutation of carnitine palmitoyltransferase 1A deficiency and long-term follow-up in Finland","volume":"160","author":"Roomets","year":"2012","journal-title":"J Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0022-3476(81)80834-7","article-title":"Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency","volume":"98","author":"Bougneres","year":"1981","journal-title":"J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ymgme.2010.07.013","article-title":"Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut","volume":"101","author":"Collins","year":"2010","journal-title":"Mol Genet Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1542\/peds.2010-0687","article-title":"Evidence for an association between infant mortality and a carnitine palmitoyltransferase 1A genetic variant","volume":"126","author":"Gessner","year":"2010","journal-title":"Pediatrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2010.07.031","article-title":"Prevalence and distribution of the c.1436C\u2013>T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infants","volume":"158","author":"Gessner","year":"2011","journal-title":"J Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ajhg.2014.09.016","article-title":"A selective sweep on a deleterious mutation in CPT1A in arctic populations","volume":"95","author":"Clemente","year":"2014","journal-title":"Am J Hum Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3760\/cma.j.issn.1003-9406.2017.02.017","article-title":"Clinical features and genetic analysis of a case with carnitine palmitoyltransferase 1A deficiency","volume":"34","author":"Cui","year":"2017","journal-title":"Chin J Med Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.13407\/j.cnki.jpp.1672-108X.2019.11.007","article-title":"Clinical characteristics of one case of carnitine palmitoyltransferase 1A deficiency and analysis of CPT1A gene mutation","volume":"25","author":"Zhang","year":"2019","journal-title":"J Pediatr Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13052-021-01136-y","article-title":"Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report","volume":"47","author":"Gan","year":"2021","journal-title":"Ital J Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3760\/cma.j.cn112137-20200724-02206","article-title":"Clinical features and gene mutations of 6 patients with carnitine palmitoyltransferase 1A deficiency","volume":"101","author":"Yu","year":"2021","journal-title":"Chin J Med Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3760\/cma.j.cn511374-20200309-00146","article-title":"Analysis of a child with carnitine palmitoyl transferase 1A deficiency due to variant of CPT1A gene","volume":"38","author":"Zhou","year":"2021","journal-title":"Chin J Med Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1515\/jpem-2020-0694","article-title":"Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China","volume":"34","author":"Lin","year":"2021","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fgene.2019.00802","article-title":"Biochemical, clinical, and genetic characteristics of short\/branched chain Acyl-CoA dehydrogenase deficiency in Chinese patients by newborn screening","volume":"10","author":"Lin","year":"2019","journal-title":"Front Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-010-9076-8","article-title":"Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting","volume":"33","author":"Lindner","year":"2010","journal-title":"J Inherit Metab Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"969141320973690","DOI":"10.1177\/0969141320973690","article-title":"Incidence of inborn errors of metabolism detected by tandem mass spectrometry in China: a census of over seven million newborns between 2016 and 2017","volume":"2020","author":"Deng","year":"2020","journal-title":"J Med Screen."},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/8904_2011_35","article-title":"Normal levels of plasma free carnitine and acylcarnitines in follow-up samples from a presymptomatic case of carnitine palmitoyl transferase 1 (CPT1) deficiency detected through newborn screening in Denmark","volume":"3","author":"Borch","year":"2012","journal-title":"JIMD Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20010","DOI":"10.3390\/ijns3020010","article-title":"Utility of genetic testing for confirmation of abnormal newborn screening in disorders of long-chain fatty acids: a missed case of carnitine palmitoyltransferase 1A (CPT1A) deficiency","volume":"3","author":"Dowsett","year":"2017","journal-title":"Int J Neonatal Screen."},{"key":"B21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/gim.2016.202","article-title":"Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data","volume":"19","author":"Fohner","year":"2017","journal-title":"Genet Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/mgme.2001.3149","article-title":"Hepatic carnitine palmitoyl transferase 1 (CPT1 A) deficiency in North American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program","volume":"73","author":"Prasad","year":"2001","journal-title":"Mol Genet Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/mgme.2001.3176","article-title":"Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community","volume":"73","author":"Prip-Buus","year":"2001","journal-title":"Mol Genet Metab."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.771922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T06:43:52Z","timestamp":1636699432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.771922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":23,"alternative-id":["10.3389\/fped.2021.771922"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.771922","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"article-number":"771922"}}